Ankur Pandya
@AnkurFactorial
ID:107296071
https://www.hsph.harvard.edu/profile/ankur-pandya/ 22-01-2010 03:25:00
7,8K Tweets
6,2K Followers
2,9K Following
Follow People
Michael L. Barnett
Associate professor of health policy at @HarvardChanSPH @HarvardHPM @harvardmed studying health care delivery. Primary care physician @BrighamWomens.
Stacie Dusetzina
Health services researcher at Vanderbilt Health Policy. Avid coffee drinker, investigator of drug policies & prices. RT not an endorsement. Opinions are mine.
A Jay Holmgren
Assistant Professor @UCSF. Digital health, economics, informatics. PhD @Harvard, 2x @UMich alum.
Adrianna McIntyre (@adrianna.bsky.social)
Assistant Professor (@HarvardHPM) studying strategies to improve take-up and retention of health insurance and politics of health reform. @adrianna.bsky.social
Yevgeniy Feyman 🟣
Doing health policy stuff in DC. HSR PhD from @busph. Doggy dad. Opinions my own. Zionist. 🇮🇱
Extraordinary news this week as CMSGov includes *THREE* 1st line drugs for #HeartFailure for price negotiation - 2 #SGLT2 and 1 #ARNI
Discounts could make #quadrupletherapy #affordable for more patients and more than just borderline #costeffective as it is now.
Exciting! My chapter Measuring & Valuing Health Outcomes was published🎉 In Handbook of Health Economics in Vaccines
CO-AUTHORS Ankur Pandya Stéphane Verguet
Logan Brenzel, PhD David Bishai Bill Padula, PhD Immunization Economics
#vaccineeconomics
doi.org/10.1093/oso/97…
doi.org/10.1093/oso/97…
Navigating the academic job market can feel like uncharted territory.🔍
Join us as we, as recent candidates, share our journey to demystify the process!🗺️ Expect casual conversation & ample Q&A time!
Trainees, this is for you!🚀
Mentors, pls amplify for our Society for Medical Decision Making (SMDM) trainees🙏
Good STAT piece here covering this JAMA Network Open paper on racial and ethnic bias in risk prediction. Great quotes from Ankur Pandya! jamanetwork.com/journals/jaman…
Is guideline quadruple therapy for #HeartFailure with reduced EF cost-effective?
We investigated. Today in Circ: CQO, we Ankur Pandya Aferdita Spahillari report a borderline finding: ICER $98,500/QALY
Key Point: It's the Drug Prices.
A Thread:
ahajournals.org/doi/abs/10.116…